Avoro Capital Advisors LLC Catalyst Pharmaceuticals, Inc. Transaction History

Avoro Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $8.63 Million - $16.3 Million	-4,497,042 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $441,380 - $749,955	-195,301 Reduced 4.16%	4,497,042 $14 Million
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $1.91 Million - $3.21 Million	800,000 Added 20.55%	4,692,343 $11.2 Million
Q4 2017 Feb 14, 2018	SELL	$2.51 - $4.4 $1.87 Million - $3.27 Million	-743,402 Reduced 16.04%	3,892,343 $15.2 Million
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $11.1 Million - $13.6 Million	4,635,745	4,635,745 $11.7 Million

390

105M

164K

439K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.38B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.